Surface Oncology, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Surface Oncology, Inc. has filed 406 SEC EDGAR filings since 17 Nov 2017

SEC filing history

Showing 26-50 of 72 matching filings.

Per page
25
Current page
2
8-K File 001-38459

8-K

Filing date
05 May 2021
Reporting date
05 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38459

8-K

Filing date
03 May 2021
Reporting date
23 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38459

8-K

Filing date
27 Apr 2021
Reporting date
26 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38459

8-K

Filing date
09 Mar 2021
Reporting date
09 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38459

8-K

Filing date
09 Mar 2021
Reporting date
09 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38459

8-K

Filing date
24 Feb 2021
Reporting date
24 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38459

8-K

Filing date
11 Feb 2021
Reporting date
09 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38459

8-K

Filing date
11 Jan 2021
Reporting date
11 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38459

8-K

Filing date
17 Dec 2020
Reporting date
16 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38459

8-K

Filing date
25 Nov 2020
Reporting date
25 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38459

8-K

Filing date
13 Nov 2020
Reporting date
13 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38459

8-K

Filing date
12 Nov 2020
Reporting date
11 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38459

8-K

Filing date
10 Nov 2020
Reporting date
10 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38459

8-K

Filing date
09 Nov 2020
Reporting date
09 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38459

8-K

Filing date
09 Nov 2020
Reporting date
09 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38459

8-K

Filing date
26 Oct 2020
Reporting date
26 Oct 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38459

8-K

Filing date
11 Aug 2020
Reporting date
11 Aug 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38459

8-K

Filing date
12 Jun 2020
Reporting date
10 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38459

8-K

Filing date
22 May 2020
Reporting date
22 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38459

8-K

Filing date
20 May 2020
Reporting date
19 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38459

8-K

Filing date
15 May 2020
Reporting date
15 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38459

8-K

Filing date
14 May 2020
Reporting date
14 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38459

8-K

Filing date
12 May 2020
Reporting date
12 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38459

8-K

Filing date
24 Apr 2020
Reporting date
23 Apr 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38459

8-K

Filing date
17 Mar 2020
Reporting date
17 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .